Financials Corbion N.V.

Equities

CRBN

NL0010583399

Specialty Chemicals

Market Closed - Euronext Amsterdam 11:35:19 2024-04-26 am EDT 5-day change 1st Jan Change
19.28 EUR +3.49% Intraday chart for Corbion N.V. +2.06% -0.52%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,652 2,715 2,443 1,879 1,149 1,139 - -
Enterprise Value (EV) 1 1,956 2,999 2,904 1,879 1,149 1,574 1,597 1,540
P/E ratio 65.4 x 37.5 x 31.4 x 21.1 x 15.9 x 21.5 x 13.8 x 11.1 x
Yield 1.99% 1.21% 1.35% - - 3.03% 3.18% 3.58%
Capitalization / Revenue 1.69 x 2.75 x 2.28 x 1.29 x 0.8 x 0.86 x 0.81 x 0.78 x
EV / Revenue 2 x 3.04 x 2.71 x 1.29 x 0.8 x 1.19 x 1.14 x 1.06 x
EV / EBITDA 13.4 x 18.9 x 21.4 x 10.2 x 5.99 x 9.85 x 7.57 x 6.54 x
EV / FCF 204 x 149 x -23 x - - 44.6 x 34.1 x 30.6 x
FCF Yield 0.49% 0.67% -4.35% - - 2.24% 2.93% 3.27%
Price to Book 3.12 x 5.27 x 4.41 x - - 1.7 x 1.59 x 1.44 x
Nbr of stocks (in thousands) 58,765 58,820 58,952 59,013 59,273 59,091 - -
Reference price 2 28.12 46.15 41.44 31.84 19.38 19.28 19.28 19.28
Announcement Date 3/9/20 3/5/21 2/25/22 3/3/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 976.4 986.5 1,071 1,458 1,444 1,320 1,407 1,455
EBITDA 1 145.9 158.8 135.8 184.4 191.8 159.8 211.1 235.4
EBIT 1 85 98.5 71.7 108 107.2 83.03 124.3 148.9
Operating Margin 8.71% 9.98% 6.7% 7.41% 7.42% 6.29% 8.84% 10.24%
Earnings before Tax (EBT) 1 44.7 87.7 86.5 116.4 85.3 87 103.9 134
Net income 1 25.8 73.1 78.3 90 88.7 52.35 90 103
Net margin 2.64% 7.41% 7.31% 6.17% 6.14% 3.97% 6.4% 7.08%
EPS 2 0.4300 1.230 1.320 1.510 1.220 0.8967 1.393 1.735
Free Cash Flow 1 9.6 20.1 -126.3 - - 35.3 46.8 50.4
FCF margin 0.98% 2.04% -11.79% - - 2.67% 3.33% 3.46%
FCF Conversion (EBITDA) 6.58% 12.66% - - - 22.09% 22.17% 21.41%
FCF Conversion (Net income) 37.21% 27.5% - - - 67.43% 52% 48.93%
Dividend per Share 2 0.5600 0.5600 0.5600 - - 0.5850 0.6125 0.6900
Announcement Date 3/9/20 3/5/21 2/25/22 3/3/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2023 Q2 2023 S1 2023 Q3
Net sales 1 492.2 515.6 282 273.2 320.1 367.3 378.4 - 353
EBITDA 1 83.8 77.1 36.4 22.3 40 - 48.4 - 39.3
EBIT 45.7 70.3 - - - 28.9 - 53.6 -
Operating Margin 9.28% 13.63% - - - 7.87% - - -
Earnings before Tax (EBT) - - - - - - - - -
Net income - - - - - - - - -
Net margin - - - - - - - - -
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 8/7/20 8/10/21 10/27/21 2/25/22 4/29/22 8/10/22 8/10/23 8/10/23 10/26/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 303 284 461 - - 435 458 401
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.079 x 1.79 x 3.395 x - - 2.721 x 2.171 x 1.702 x
Free Cash Flow 1 9.6 20.1 -126 - - 35.3 46.8 50.4
ROE (net income / shareholders' equity) 8.77% 14% 14.6% - - 6.9% 11.8% 14.1%
ROA (Net income/ Total Assets) 4.47% 6.75% - - - - - -
Assets 1 576.8 1,083 - - - - - -
Book Value Per Share 2 9.000 8.760 9.400 - - 11.30 12.10 13.40
Cash Flow per Share 2 1.940 1.850 0.3800 - - 2.100 3.170 3.390
Capex 1 82.6 88.9 149 - - 108 112 122
Capex / Sales 8.46% 9.01% 13.89% - - 8.21% 7.96% 8.38%
Announcement Date 3/9/20 3/5/21 2/25/22 3/3/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
19.28 EUR
Average target price
23.48 EUR
Spread / Average Target
+21.80%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRBN Stock
  4. Financials Corbion N.V.